Literature DB >> 18551144

Molecular analysis of human cancer cells infected by an oncolytic HSV-1 reveals multiple upregulated cellular genes and a role for SOCS1 in virus replication.

Y Y Mahller1, B Sakthivel, W H Baird, B J Aronow, Y-H Hsu, T P Cripe, R Mehrian-Shai.   

Abstract

Oncolytic herpes simplex viruses (oHSVs) are promising anticancer therapeutics. We sought to characterize the functional genomic response of human cancer cells to oHSV infection using G207, an oHSV previously evaluated in a phase I trial. Five human malignant peripheral nerve sheath tumor cell lines, with differing sensitivity to oHSV, were infected with G207 for 6 h. Functional genomic analysis of virus-infected cells demonstrated large clusters of downregulated cellular mRNAs and smaller clusters of those upregulated, including 21 genes commonly upregulated in all five lines. Of these, 7 are known to be HSV-1 induced and 14 represent novel virus-regulated genes. Gene ontology analysis revealed that a majority of G207-upregulated genes are involved in Janus kinase/signal transducer and activator of transcription signaling, transcriptional regulation, nucleic acid metabolism, protein synthesis and apoptosis. Ingenuity networks highlighted nodes for AP-1 subunits and interferon signaling via STAT1, suppressor of cytokine signaling-1 (SOCS1), SOCS3 and RANTES. As biological confirmation, we found that virus-mediated upregulation of SOCS1 correlated with sensitivity to G207 and that depletion of SOCS1 impaired virus replication by >10-fold. Further characterization of roles provided by oHSV-induced cellular genes during virus replication may be utilized to predict oncolytic efficacy and to provide rational strategies for designing next-generation oncolytic viruses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18551144      PMCID: PMC2852536          DOI: 10.1038/cgt.2008.40

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  51 in total

1.  The patterns of accumulation of cellular RNAs in cells infected with a wild-type and a mutant herpes simplex virus 1 lacking the virion host shutoff gene.

Authors:  Brunella Taddeo; Audrey Esclatine; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-12       Impact factor: 11.205

Review 2.  Inhibitors of cytokine signal transduction.

Authors:  Samuel Wormald; Douglas J Hilton
Journal:  J Biol Chem       Date:  2003-11-07       Impact factor: 5.157

3.  The tumor suppressor activity of SOCS-1.

Authors:  Robert Rottapel; Subburaj Ilangumaran; Christopher Neale; Jose La Rose; Jenny M-Y Ho; Melody H-H Nguyen; Dwayne Barber; Patrice Dubreuil; Paulo de Sepulveda
Journal:  Oncogene       Date:  2002-06-27       Impact factor: 9.867

4.  Herpes simplex virus infections are arrested in Oct-1-deficient cells.

Authors:  Mauricio L Nogueira; Victoria E H Wang; Dean Tantin; Phillip A Sharp; Thomas M Kristie
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

5.  The herpes simplex virus 1 UL41 gene-dependent destabilization of cellular RNAs is selective and may be sequence-specific.

Authors:  Audrey Esclatine; Brunella Taddeo; Linton Evans; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

6.  Suppressor of cytokine signaling 1 regulates an endogenous inhibitor of a mast cell protease.

Authors:  Subburaj Ilangumaran; Dina Finan; Jason Raine; Robert Rottapel
Journal:  J Biol Chem       Date:  2003-08-12       Impact factor: 5.157

7.  Latent herpes simplex virus infection of sensory neurons alters neuronal gene expression.

Authors:  Martha F Kramer; W James Cook; Frederick P Roth; Jia Zhu; Holly Holman; David M Knipe; Donald M Coen
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

8.  Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.

Authors:  Arnar Geirsson; Indu Paliwal; Raymond J Lynch; Alfred L M Bothwell; Graeme L Hammond
Journal:  Transplantation       Date:  2003-07-27       Impact factor: 4.939

9.  Gene expression profiling in the HSV-1 latently infected mouse trigeminal ganglia following hyperthermic stress.

Authors:  Shiro Higaki; Bryan Gebhardt; Walter Lukiw; Hilary Thompson; James Hill
Journal:  Curr Eye Res       Date:  2003 Mar-Apr       Impact factor: 2.424

10.  SOCS1 silencing enhances antitumor activity of type I IFNs by regulating apoptosis in neuroendocrine tumor cells.

Authors:  Kathrin Zitzmann; Stephan Brand; Enrico N De Toni; Sebastian Baehs; Burkhard Göke; Jennifer Meinecke; Gerald Spöttl; Heinrich H H D Meyer; Christoph J Auernhammer
Journal:  Cancer Res       Date:  2007-05-15       Impact factor: 12.701

View more
  14 in total

1.  Immune gene expression in swine macrophages expressing the Torque Teno Sus Virus1 (TTSuV1) ORF-1 and 2 proteins.

Authors:  Pankaj Singh; Sheela Ramamoorthy
Journal:  Virus Res       Date:  2016-04-05       Impact factor: 3.303

2.  Assessment of oncolytic HSV efficacy following increased entry-receptor expression in malignant peripheral nerve sheath tumor cell lines.

Authors:  J D Jackson; A M McMorris; J C Roth; J M Coleman; R J Whitley; G Y Gillespie; S L Carroll; J M Markert; K A Cassady
Journal:  Gene Ther       Date:  2014-08-14       Impact factor: 5.250

3.  Lack of strong anti-viral immune gene stimulation in Torque Teno Sus Virus1 infected macrophage cells.

Authors:  P Singh; S Ramamoorthy
Journal:  Virology       Date:  2016-05-11       Impact factor: 3.616

Review 4.  Viral exploitation of host SOCS protein functions.

Authors:  Lisa Nowoslawski Akhtar; Etty N Benveniste
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

5.  STAT1 and NF-κB Inhibitors Diminish Basal Interferon-Stimulated Gene Expression and Improve the Productive Infection of Oncolytic HSV in MPNST Cells.

Authors:  Joshua D Jackson; James M Markert; Li Li; Steven L Carroll; Kevin A Cassady
Journal:  Mol Cancer Res       Date:  2016-02-16       Impact factor: 5.852

6.  Suppressor of Cytokine Signaling 3 Is an Inducible Host Factor That Regulates Virus Egress during Ebola Virus Infection.

Authors:  Atsushi Okumura; Angela L Rasmussen; Peter Halfmann; Friederike Feldmann; Akihiko Yoshimura; Heinz Feldmann; Yoshihiro Kawaoka; Ronald N Harty; Michael G Katze
Journal:  J Virol       Date:  2015-08-05       Impact factor: 5.103

7.  The HSV-2 mutant DeltaPK induces melanoma oncolysis through nonredundant death programs and associated with autophagy and pyroptosis proteins.

Authors:  A G Colunga; J M Laing; L Aurelian
Journal:  Gene Ther       Date:  2009-10-01       Impact factor: 5.250

8.  HSV-1-induced SOCS-1 expression in keratinocytes: use of a SOCS-1 antagonist to block a novel mechanism of viral immune evasion.

Authors:  Kenneth G Frey; Chulbul M I Ahmed; Rea Dabelic; Lindsey D Jager; Ezra N Noon-Song; S Mohammad Haider; Howard M Johnson; Nancy J Bigley
Journal:  J Immunol       Date:  2009-06-19       Impact factor: 5.422

9.  HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1).

Authors:  Stéphanie Olière; Eduardo Hernandez; Agnès Lézin; Meztli Arguello; Renée Douville; Thi Lien-Anh Nguyen; Stéphane Olindo; Gérard Panelatti; Mirdad Kazanji; Peter Wilkinson; Rafick-Pierre Sékaly; Raymond Césaire; John Hiscott
Journal:  PLoS Pathog       Date:  2010-11-04       Impact factor: 6.823

10.  Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastoma.

Authors:  Lauren A Gillory; Michael L Megison; Jerry E Stewart; Elizabeth Mroczek-Musulman; Hugh C Nabers; Alicia M Waters; Virginia Kelly; Jennifer M Coleman; James M Markert; G Yancey Gillespie; Gregory K Friedman; Elizabeth A Beierle
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.